Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
November 1, 2017
Identifying Hemodynamic Determinants of Pulse Pressure: A Combined Numerical and Physiological Approach
Samuel Vennin, Ye Li, Marie Willemet, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 23, 2017
Reduced First-Phase Ejection Fraction and Sustained Myocardial Wall Stress in Hypertensive Patients With Diastolic Dysfunction: A Manifestation of Impaired Shortening Deactivation That Links Systolic to Diastolic Dysfunction and Preserves Systolic Ejection Fraction
Haotian Gu, Ye Li, Henry Fok, et al.
IEEE Transactions on Bio-Medical Engineering
|
November 12, 2021
Novel Pressure Wave Separation Analysis for Cardiovascular Function Assessment Highlights Major Role of Aortic Root
Samuel Vennin, Ye Li, Jorge Mariscal-Harana, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 27, 2014
Dominance of the forward compression wave in determining pulsatile components of blood pressure: similarities between inotropic stimulation and essential hypertension
Henry Fok, Antoine Guilcher, Sally Brett, et al.
Circulation
|
December 24, 2014
Paradoxical normoxia-dependent selective actions of inorganic nitrite in human muscular conduit arteries and related selective actions on central blood pressures
Sami A Omar, Henry Fok, Katharina D Tilgner, et al.
Kidney International
|
August 23, 2022
Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis
Tariq E Farrah, Vanessa Melville, Alicja Czopek, et al.
British Journal of Clinical Pharmacology
|
July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants
Maria B Goncalves, Tim Mant, Jörg Täubel, et al.
JAMA
|
April 8, 2024
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial
Steven E Nissen, Kathy Wolski, Gerald F Watts, et al.
JAMA
|
November 18, 2024
Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
Steven E Nissen, Qiuqing Wang, Stephen J Nicholls, et al.
Frontiers in Molecular Neuroscience
|
September 4, 2024
C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repair
Maria B Goncalves, Yue Wu, Earl Clarke, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Hypertension (Dallas, Tex. : 1979)
|
November 1, 2017
Identifying Hemodynamic Determinants of Pulse Pressure: A Combined Numerical and Physiological Approach
Samuel Vennin, Ye Li, Marie Willemet, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 23, 2017
Reduced First-Phase Ejection Fraction and Sustained Myocardial Wall Stress in Hypertensive Patients With Diastolic Dysfunction: A Manifestation of Impaired Shortening Deactivation That Links Systolic to Diastolic Dysfunction and Preserves Systolic Ejection Fraction
Haotian Gu, Ye Li, Henry Fok, et al.
IEEE Transactions on Bio-Medical Engineering
|
November 12, 2021
Novel Pressure Wave Separation Analysis for Cardiovascular Function Assessment Highlights Major Role of Aortic Root
Samuel Vennin, Ye Li, Jorge Mariscal-Harana, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 27, 2014
Dominance of the forward compression wave in determining pulsatile components of blood pressure: similarities between inotropic stimulation and essential hypertension
Henry Fok, Antoine Guilcher, Sally Brett, et al.
Circulation
|
December 24, 2014
Paradoxical normoxia-dependent selective actions of inorganic nitrite in human muscular conduit arteries and related selective actions on central blood pressures
Sami A Omar, Henry Fok, Katharina D Tilgner, et al.
Kidney International
|
August 23, 2022
Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis
Tariq E Farrah, Vanessa Melville, Alicja Czopek, et al.
British Journal of Clinical Pharmacology
|
July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants
Maria B Goncalves, Tim Mant, Jörg Täubel, et al.
JAMA
|
April 8, 2024
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial
Steven E Nissen, Kathy Wolski, Gerald F Watts, et al.
JAMA
|
November 18, 2024
Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
Steven E Nissen, Qiuqing Wang, Stephen J Nicholls, et al.
Frontiers in Molecular Neuroscience
|
September 4, 2024
C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repair
Maria B Goncalves, Yue Wu, Earl Clarke, et al.
Page
of 3